MGIA
REGN icon

Moneta Group Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Moneta Group Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$370K Buy
478
+51
+12% +$39K ﹤0.01% 578
2025
Q4 		$330K Sell
427
-16
-4% -$10.9K ﹤0.01% 610
2025
Q3 		$249K Sell
443
-7
-2% -$3.96K ﹤0.01% 679
2025
Q2 		$236K Sell
450
-340
-43% -$190K ﹤0.01% 620
2025
Q1 		$501K Buy
790
+39
+5% +$26.8K 0.01% 419
2024
Q4 		$535K Sell
751
-107
-12% -$89.8K 0.01% 400
2024
Q3 		$902K Buy
858
+21
+3% +$23.4K 0.01% 290
2024
Q2 		$880K Buy
837
+159
+23% +$154K 0.01% 285
2024
Q1 		$653K Buy
678
+109
+19% +$104K 0.01% 329
2023
Q4 		$500K Sell
569
-2
-0.4% -$1.65K 0.01% 340
2023
Q3 		$470K Sell
571
-3
-0.5% -$2.36K 0.01% 330
2023
Q2 		$412K Sell
574
-69
-11% -$53.2K 0.01% 365
2023
Q1 		$528K Buy
643
+127
+25% +$95.8K 0.01% 314
2022
Q4 		$391K Sell
516
-489
-49% -$361K 0.01% 331
2022
Q3 		$692K Sell
1,005
-2
-0.2% -$1.26K 0.03% 227
2022
Q2 		$595K Buy
1,007
+453
+82% +$294K 0.02% 278
2022
Q1 		$387K Buy
+554
New +$350K 0.02% 322

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Moneta Group Investment Advisors's REGN Position: Q1 2026 in Review

Moneta Group Investment Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q1 2026, buying an estimated $39K and bringing the position to 478 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #578.

Moneta Group Investment Advisors first reported a position in REGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $902K in Q3 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Moneta Group Investment Advisors held 478 shares of Regeneron Pharmaceuticals worth $370K as of Q1 2026.
  • Moneta Group Investment Advisors bought 51 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $39K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Moneta Group Investment Advisors's portfolio in Q1 2026, its #578 holding.
  • Moneta Group Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • Moneta Group Investment Advisors's Regeneron Pharmaceuticals position peaked at $902K in Q3 2024.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.